June 2010 for renal March cell Renal cell 2012 outside outside Aus and carcinoma; (renal cell Sept April 2012 Pazopanib Votrient® 10 Yes 8 None Nov funding funding NZ soft tissue 2010 for mRCC 2012 for restrictions restrictions sarcoma July soft 2013 (soft tissue tissue sarcoma) Ipilimumab treated Cost listed for no or varied Aus and netastatic Sept listed Sept no 15 Yes metastatic 36 as per NZ 2015 melanoma no 2015 2016 registration melanoma July 2015 funding patients ; advanced gastric cancer
Pazopanib Votrient® Aus and NZ 10 Yes Renal cell carcinoma; soft tissue sarcoma 8 None June 2010 for renal cell Nov 2012 for soft tissue March 2012 (renal cell July 2013 (soft tissue sarcoma) outside funding restrictions Sept 2010 April 2012 for mRCC outside funding restrictions Aus and NZ 15 Yes Ipilimumab treated or metastatic melanoma patients ; advanced gastric cancer 36 Cost varied as per 2015 listed for netastatic melanoma July 2015 no no funding Sept 2015 listed Sept 2016 no registration
1-s2.0-S0168851017303457-mmc1.docx